Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Conavi Medical Corp V.TMD


Primary Symbol: T.TMD

Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.


TSX:TMD - Post by User

Post by flyguy8888on Jan 17, 2021 4:42pm
535 Views
Post# 32316109

buyout coming from Medtronic

buyout coming from MedtronicBuyout from Medtronic willl dwarf current pps. Bigtime. God bless and good luck everyone.
isrg davinci has a monopoly in the single port arena. 0 competition. Tmdi sport enos will be the only alternative. Also many small surgical hospitals don’t want anything to do with davinci because of the cost and size. Tmdi has 150 patents a fab ip that can be used for more than just sp robots and of course the big prize sport enos sp tech to end davinci monopoly once and for all.
Tmdi got the goods and the mdt licensing deal proved it but 1st Medtronic wanted TMDI to fix hugo. God bless and good luck everyone
<< Previous
Bullboard Posts
Next >>